Shareholders to Vote on Significant Share Issuance Authority and Equity Plan Expansion

summarizeSummary

Amarin is seeking shareholder approval for proposals that could lead to substantial share dilution, including a general authority to allot up to 18% of existing share capital and an increase of 15 million shares for its stock incentive plan.

check_boxKey Events

• Significant Share Allotment Authority

  Shareholders will vote on an ordinary resolution to authorize the Board to issue shares up to an aggregate nominal amount of £37,750,000, representing approximately 18% of the existing issued share capital. If all authorized shares were issued, this would result in approximately 18.0% dilution.

• Stock Incentive Plan Expansion

  The company seeks to amend its 2020 Stock Incentive Plan, increasing the share reserve by 15,000,000 Ordinary Shares. This expansion, valued at approximately $10.8 million, would bring the total potential dilution from the entire plan to approximately 17.88% of current outstanding shares.

• Re-submission of Pre-emptive Rights Disapplication

  A special resolution is proposed to permit the Board to issue shares without statutory pre-emption rights for up to £20,970,000 in nominal value (approximately 10% of existing share capital). This proposal was rejected in 2025, leading to cash compensation for non-employee directors, which the company aims to rectify for better incentive alignment.

• Board Member Resignations

  Two non-executive directors, Dr. Paul Cohen and Mr. Oliver O'Connor, will not stand for re-election and will resign from the Board effective immediately before the Annual General Meeting.

auto_awesomeAnalysis

Amarin is requesting broad shareholder approval for several proposals at its upcoming Annual General Meeting, most notably a general authority to issue shares representing approximately 18% of its current outstanding capital and an increase of 15 million shares to its 2020 Stock Incentive Plan. If all authorized shares were issued, this would result in significant dilution for existing shareholders. Additionally, Amarin is re-proposing the disapplication of pre-emptive rights for up to 10% of its share capital, a measure previously rejected by shareholders in 2025, which the company states is crucial for director compensation and operational flexibility. These capital-raising and compensation-related proposals are presented in the context of the company's ongoing efforts to strengthen its financial position and retain talent, following a year of reduced net loss and positive cash flow.